Mystocks mentioned BGMD. That stock was up over 80% to 1.08 on 21 million shares(avg 300k) on CMS reimbursement news. This is the power of CMS.
Vaso is very close to getting eecp a CMS upgrade(they recently received the European equivalent) which would lead to more acceptance and higher coverage. Short will have unlimited losses if CMS news comes shortly. Its hard to figure how short would not appreciate his risk here.
Longs- keep those shares. We have all watched vaso go higher, day after day, when base is broken.
This final determination by CMS comes in response to BG Medicine's request for reconsideration of the 2013 CMS determination and will apply effective January 1, 2014. The 2014 national limitation amount applies across the U.S. except in Ohio and West Virginia where rates of $23.99 and $26.40, respectively, will apply. In addition, the 2014 national limitation amount is subject to a 2% sequestration applicable to Medicare services if the current sequestration is extended beyond January 15, 2014.
Mystocks, no need to place "short order". Just ask if "hard to borrow."
Anyway, don't think they will let you place short trade if long; cant short against the box
My last words for those poster longs here is to stay the coarse tomorrow. This short is real and extended.
What you say smalls?
Wow, this must be one #$%$ off short. Get this, over 200,000 shares shorted today. That means, all those shares at 30 cents that took all day to work off were the short offering shares. A more obvious attempt to manipulate prices lower would be hard to find. This guy is easily short a half million shares in the last month. If longs stay committed and do not offer shares for sale on this breakout, this guy could be in real trouble.
MM shorted a ton at .28, believing he could keep stock under that level. When buyers took him out, he defended the 30 cent level for 100's of thousands of shares. Now, that has failed. At some point, firm will force the mm to cover his failed attempt to make stock go lower; its just risk management 101.
If, and when that happens, there will not be enough stock for him to buy, as most held by a few large owners and committed shareholders here.
Short squeeze is an over used term in the market, but all the ingredients are here. Its a shame mm shorting has caused stock to be underpriced. We would be closer to 50 cents without all his "supply". But, a large short who is forced to buy can cause a violent price move; a wonderful thing to see if you are long.
Every dog has his day; we shall see..................................
We had a size bid at .3 which was upped at the close. That's what really counts. Also, big spread and small size on offer is very favorable to higher prices. Next resistance at .37
Up 17% on 5 times avg volume. That should get some attention for tomorrow. If charts ever mean anything, this long base breakout should at least get to highs(maybe beyond) of the year. Previous breakouts have really run hard and fast.
Great Q coming up, 10 mil in cash, company buyback, bunch of new products, and main product (eecp) getting traction. Whats not to like???????? How many BB stocks have all these fundamentals?
Stock just broke over 7.2 resistance on good volume. Company issued improved guidance last CC, and said as long as temperature isn't above normal, they would meet that guidance. Well, it is now very much colder than their improved guidance took into account, so #'s will be even better. Cold weather/increase demand is very good.
2 large buyers in the stock according to recent 13Gs;
James Pattison owns 14.7 million shares as of 10/3/13
Ronald Joyce owns 15.2 million shares as of 11/26/13
On 9/13/13 Mr Joyce owned 12.7 million shares according to 13G........you do the math.
MM is supposed to even out short before the end of day(don't take a position). But, there are many exceptions and working in the gray area has never been a problem for these guys.
Volume will eventually win the day
2 blocks done at .3; 20,500 and 25,000. Now another for 30,000. Is that short supply on offer? Will be interesting to see. And, at what point does short start covering and really add to gains here.
These buys look like they might be some type of insider activity.
30k shorted today and 25k Friday. Size offer is short again, trying to force down share price. Ma had better wake up and confront this issue. Better companies have been destroyed by naked short sellers.
If Ma doesn't believe these numbers, he should go to finra site himself.
There is no reason short activity should be so high. In the last 2 weeks 200,000 shares have been shorted(added to supply). So, buying that should normally take out supply and push stock naturally higher, has no effect and MM can add to supply anytime he wants.
We need a dividend or larger buyback, or another MM to take this monopoly from this thief. Company cheers its rev increases, but ignores the only metric that counts.............................Shareholder Value.
Lots of shares shorted at .28 last week. More at .2601 to pressure longs to bail?. We shall see from #'s soon enough.
Its all manipulation in front of the best Q (management words) of the year. Gotta be a bidder here.
Short is really pressuring stock now. Ma needs to address this with a new buyback announcement or a management coordinated inside buying program.. Ma is not proactive enough.
Stonybrook center is now called the Ray Dalio Center for Cardio Wellness and Preventive Research.
Assuming Dalio believes that eecp is the preventive answer to heart disease and Dr Poons unique imaging tools will show the physical benefits to the heart that can no longer be ignored by the consensus driven cardio community. This is the type of fact based research we needed 10 years ago. But maybe, just maybe, with the violent changes in healthcare, and big smart money behind us, 2014 will be the huge year for eecp and vaso.
The Center has been funded through a generous gift from Ray Dalio, founder of the investment firm Bridgewater Associates and who has appeared on the annual Time magazine list of the 100 most influential people in the world. In his words, “The research being conducted by Dr. Poon merits significant support, because the research is innovative and potential applications for patients are so enormous. This is one of the best investments possible to make because of the return it will provide, benefiting generations to come.”
Dr. Poon is a pioneer on the use of coronary computed tomographic angiography (CCTA) to evaluate cardiovascular disease. CCTA is a non-invasive heart imaging test that produces a “photograph” of the heart in motion to help determine if fatty deposits or plaque has narrowed a patient’s coronary arteries. Since joining Stony Brook Medicine in 2009, Dr. Poon’s innovative CCTA research and clinical practice has reduced hospital admissions of patients presenting with chest pain in the Emergency Department (ED) by incorporating CCTA. The process enables physicians to more accurately and quickly diagnose the causes of chest pain; determine if heart disease is the cause of chest pain, or rule it out, thereby halting additional testing or unnecessary invasive procedures in patients; and saves time, medical costs, and lives.
The Wellness & Prevention Research Center was set up there in May. According to Dr Poon, patients will undergo a 3 year study after eecp treatments, with 3 to 6 months assessments. It is very possible, news could be coming out shortly showing some interim results.
Mystock, you and your buddy juststeve need to move on and stop dumbing down this board. Your continued pumping and other chart comparisons really make you less credible than you could possibly know.
Take your "stock chats" to another board and give us all a break. You clearly are clueless when it comes to vaso.
Short wants no part of this stock ticking over .3. So, he puts out 100k on the offer at .297. No long looking to liquidate would be so stupid as to show that size, when he could piece it out. The manipulation here is off the chart and management should address.